I.A. FROLYCHEV, N.A. POZDEYEVA

Cheboksary branch of the S. Fyodorov Eye Microsurgery Federal State Institution, 10 Traktorostroiteley Pr., Cheboksary, Russian Federation, 428028

 Frolychev I.A. ― Researcher, tel. (8352) 36-90-00, e-mail: ivan-f@yandex.ru

Pozdeyeva N.A. ― D. Med. Sc., Deputy Director on Research, tel. (8352) 36-90-81, e-mail: npozdeeva@mail.ru

 Despite the emergence of a wide range of antibacterial drugs, the improvement of methods for pre-, intra- and postoperative prevention of infectious complications, endophthalmitis remains an urgent problem of ophthalmic surgery. The article reveals the modern conceptions of postoperative endophthalmitis: the frequency of development, etiological causes, methods of treatment. The surgical standards of postoperative endophthalmitis treatment with detailed description of various methods and modifications of surgical treatment are described. The possibilities of using intravitreal antibacterial drugs injection to the avitreal eye, as well as for the tamponade of the vitreous cavity with silicone oil and perfluororganic compounds, are considered.

Key words: postoperative endophthalmitis, vitrectomy, intravitreal injection of antibacterial drugs.

REFERENCES

1. Aznabaev M.T., Gaysina G.Ya., Azamatova G.A. Postoperative endophthalmitis. Practical medicine, 2015, vol. 87, no. 1-2, pp. 95-99. (in Russ.).
2. Astakhov S.Yu., Vokhmyakov A.V. Endophthalmitis: Prophylaxis, Diagnostics and Management (Review of the Literature). Ophtalmology Journal, 2008, vol. 1, no. 1, pp. 35-45. (in Russ.).
3. Astakhov Yu.S., Belekhova S.G., Litvinova E.A. Infectious and sterile endophthalmitis after intravitreal injections: differential diagnosis, prevention, treatment, Ophtalmology Journal, 2017, vol. 10, no. 1, pp. 62-69. (in Russ.).
4. Vokhmyakov A.V., Okolov I.N. Postoperative Endophthalmitis: Optimal Strategy of Prophylaxis, Ophtalmology Journal, 2008, vol. 1, no. 3, pp. 47-50. (in Russ.).
5. Skladchikova Y., Stebnev V.S., Skladchikova N.I. Sharp bacterial endophthalmitis as complication of a cataract. Results of treatment. Vestnik of the Orenburg State University, 2011, no. 14 (133), pp. 337-339. (in Russ.).
6. Frolychev I.A., Pozdeyeva N.A. Vitrectomy with temporal PFOC endotamponade with silicon oil substitution in postoperative endophthalmitis treatment. Vestnik of the Orenburg State University, 2013, vol. 153, no. 4, pp. 287-290. (in Russ.).
7. Khakimov A.M. Endophthalmitis in Cataract Surgery (Review). Ophthalmosurgery, 2008, no. 2, pp. 48-54. (in Russ.).
8. Barry P.,Cordovés L., Gardner S. ESCRS Guidelines for Prevention and Treatment of Endophthalmitis Following Cataract Surgery: Data, Dilemmas and conclusion, 2013, 44 p.
9. Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg, 2007. 33 p.
10. Shorstein H., Winthrop K.L., Herrinton L.J. Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department. J Cataract Refract Surg, 2013, no. 39, pp. 8-14.
11. Sheng Y., Sun W., Gu Y., Lou J., et al. Endophthalmitis after cataract surgery in China 1995-2009. J Cataract Refract Surg, 2011, no. 37, pp. 15-22.
12. Czajka M.P., Byhr E., Olivestedt G., Olofsson E.M. Endophthalmitis after small-gauge vitrectomy: a retrospective case series from Sweden. Acta Ophthalmol, 2016, no. 94(8), pp. 829-835.
13. Dave V.P, Pathengay A., Basu S., Gupta N., et al. Endophthalmitis After Pars Plana Vitrectomy: Clinical Features, Risk Factors, and Management Outcomes. Asia Pac J Ophthalmol (Phila), 2016, no. 5(3), pp. 192-5.
14. Al Rashaed S., Arevalo F., Al Sulaiman S., Masoud J., et al. Endophthalmitis Trends and Outcomes Following Glaucoma Surgery at a Tertiary Eye Care Hospital in Saudi Arabia. J Glaucoma, 2016, no. 25(2), pp. 70-5.
15. Zahid S., Musch D.C., Niziol L.M., Lichter P.R. Collaborative Initial Glaucoma Treatment Study Group. Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol, 2013, no. 155(4), pp. 674-680.
16. Collignon-Brach J. Surgery for glaucoma and endophthalmitis. Bull Soc Belge Ophtalmol, 1996, no. 260, pp. 73-7.
17. Jager R.D., Aiello L.P., Patel C., Cunningham E.T Jr. Risks of intravitreous injection: a comprehensive review. Retina, 2004, no. 24(5), pp. 676-98.
18. Chan C.C., Holland E.J. Infectious endophthalmitis after Boston type 1 keratoprosthesis implantation. Cornea, 2012, no. 31(4), pp. 346-9.
19. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol, 1995, no. 113, pp. 1479-1496.
20. Friling E., Lundström M., Stenevi , Montan P. Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg, 2013, no. 39, pp. 15-21.
21. Kunimoto D.Y., Das T., Sharma S. et al. Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Endophthalmitis Research Group. Am J Ophthalmol, 1999, no. 128, pp. 240-2.
22. Asbell P.A, Colby K.A, Deng S., et al. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am J Ophthalmol, 2008, no. 145, pp. 951-958.
23. Gower E.W., Lindsley K., Nanji A.A., et al. Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery. Cochrane Database Syst. Rev, 2013, no. 15, p. 7.
24. Martin D.F., Ficker L.A., Aguilar H.A., Gardner S.K., et al. Vitreous cefazolin levels after intravenous injection: Effects of inflammation, repeated antibiotic doses and surgery. Arch Ophthalmol. – 108: 411-414.
25. Kazaykin V.N., Ponomarev V.O., Vokhmintsev A.S., Vaynshteyn I.A. Determination of vancomycin concentration in the vitreous cavity to optimize the treatment of acute bacterial postoperative endophthalmitis. Practical medicine, 2016, vol. 2, no. 94-1, pp. 85-89. (in Russ.).
26. Höhn F., Kretz F.T., Sheth S., Natarajan S., et al. Portable single port 23-gauge vitrectomy in postoperative endophthalmitis. Clin Ophthalmol, 2015, no. 9, pp. 1457-61.
27. Bykov V.P., Gogodze M.G. Method for the treatment of endophthalmitis. Patent 2164115/ 23.11.1998.
28. Bykov V.P., Kim, A.E. Method for the treatment of endophthalmitis. Patent 2460501/ 13.05.2011.
29. Hegazy H.M, Kivilcim M., Peyman G.A., et al. Evaluation of toxicity of intravitreal ceftazidime, vancomycin, and ganciclovir in a silicone oil-filled eye. Retina, 1999, no. 19, pp. 553-7.
30. Eng K.T., Lam W.C., Parker J.A., Yücel Y.H. Retinal toxicity of intravitreal ganciclovir in rabbit eyes following vitrectomy and insertion of silicone oil. Can J Ophthalmol, 2004, no. 9(5), pp. 499-505.
31. Kivilcim M., Peyman G.A., El-Dessouky E.S., Kazi A.A., et al. Retinal toxicity of triamcinolone acetonide in silicone-filled eyes. Ophthalmic Surg. Lasers, 2000, no. 31(6), pp. 474-8.
32. Da M., Li K.K., Chan K.C., Wu E.X. et al. Distribution of Triamcinolone Acetonide after Intravitreal Injection into Silicone Oil-Filled. Eye Biomed Res. Int, 2016, pp. 548-5467.
33. Belyi Yu.A., Tereshchenko A.V., Shkvorchenko D.O., Makarov K.N., et al. The Use of Ozonized Perfluorocarbon Compounds in the Treatment of Endophthalmitis. Ophthalmosurgery, 2004, no. 1, pp. 31-34. (in Russ.).
34. Egorova E.V., White Y.A., Tereshchenko A.V., Shkvorchenko D.O., et. al. Method of surgical treatment endophthalmitis. Patent № 2223079 / 10.02.2004.
35. Frolychev I.A., Pozdeeva N.A. Tamponade of vitreal cavility with emulsion of perfluorinedecaline and antibiotics solutions in the treatment of postoperative endophthalmitis (experimental research). Medical Almanac, 2017, no. 1, pp. 87-90. (in Russ.).